The acidic characteristic of the tumor site is one of the most well‐known features and
provides a series of opportunities for cancer‐specific theranostic strategies. In this regard …

Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

With the advancement in magnetic resonance imaging (MRI) technology, traditional single T
1 or T 2 contrast agents struggle to meet the demend for accuracy imaging. In comparison …

The majority of advances in cancer therapy have been achieved based on developments in
public awareness, as well as novel diagnostic and therapeutic modalities. Treatment …

Cancer is the top cause of death globally. Developing smart nanomedicines that are
capable of diagnosis and therapy (theranostics) in one–nanoparticle systems are highly …

The past decades have shown significant advancements in the development of solid tumor
treatment. For instance, implementation of nanosystems for drug delivery has led to a …

Magnetic resonance imaging (MRI) is recognized as the most powerful clinical imaging
modality due to its ability to produce detailed three-dimensional anatomical images and high …

Photodynamic therapy (PDT) has been under development for at least 40 years. Multiple
studies have demonstrated significant anti-tumor efficacy with limited toxicity concerns. PDT …

The synergistic impact of nanomaterials is critical for novel intracellular and/or subcellular
drug delivery systems of minimal toxicity. This synergism results in a fundamental bio/nano …

Due to the complexity and particularity of cancer cell microenvironments, redox responsive
drug delivery systems (DDSs) for cancer therapy have been extensively explored …